SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3799CombinatoRx Raises $30 million in Third Venture Capital Round BOSTON, March 10 nigel bates3/10/2004
3798I think it might be too tough to compile the results from the SEC filings, sincemopgcw3/9/2004
3797Message 19898208scaram(o)uche3/9/2004
3796He had huge positions in Flamel and AME (about 15%) and each were among the veryrkrw3/9/2004
3795<i>12/31/2003 231,261 -7.1%</i> Wonder how he managed that? 2003Q4 Biomaven3/9/2004
3794Rick et al, Is there any comprehensive source of returns information for BVF? Thomas3/9/2004
3793NPS Pharmaceuticals Announces Approval of Sensipar(TM) by U.S. FDA Monday March scaram(o)uche3/8/2004
3792yeah. but I'm not advocating it.... just pointing at BGEN/Idec, Genentecscaram(o)uche3/8/2004
3791Agreed, so long as you season your holds with a few QQQ puts.tom pope3/8/2004
3790fda.gov FDA Approves First in a New Class of Drugs to Treat Hyperparathyroidismscaram(o)uche3/8/2004
3789a "buy and hold" strategy is doing well of late. (eom)scaram(o)uche3/8/2004
3788FDA Approves Amgen's Sensipar for Two Uses Monday March 8, 6:45 pm ET WASHscaram(o)uche3/8/2004
3787FORADIL(R) CERTIHALER(TM) Receives First European Approval Monday March 8, 9:00 scaram(o)uche3/8/2004
3786INGN...not too many happy shareholders on that move... I bought more on the dipzeta19613/5/2004
3785Introgen Therapeutics, Inc. Announces Proposed Common Stock Offering AUSTIN, Tenigel bates3/5/2004
3784Dundee, UK, 29 January 2004 - Cyclacel Limited, the UK-based biopharmaceutical cnigel bates3/3/2004
3783There was a time I was interested in everything Cyclacel. Wonder what it looks keokalani'nui3/3/2004
3782UK's Ark opens biotech window with successful IPO By Ben Hirschler, Europeanigel bates3/3/2004
3781biz.yahoo.com Feds review complaints Chiron hinders research. Tuesday March 2, scaram(o)uche3/2/2004
3780MGI PHARMA Announces Closing of Private Placement of Convertible Notes and OptioIcebrg3/2/2004
3779NTII raises $19mm..at what seems like a pretty big discount to current prices...mopgcw3/2/2004
3778Orchid BioSciences Announces $30 M Private Placement DOW JONES NEWSWIRES PRINCmopgcw3/1/2004
3777Vasogen Prices 8.5M-Share Offering At $5.90/Share DOW JONES NEWSWIRES mopgcw3/1/2004
3776Aphton Prices 7M Shares At $6.50 A Piece DOW JONES NEWSWIRES NEW YORK -- Aphtomopgcw3/1/2004
3775Alnylam Pharma Files IPO For Up To $86.3M Of Common Stk WASHINGTON -- Amopgcw3/1/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News